News
Alkem Sees 8-11% Growth For Indian Pharmaceutical Industry
When the epidemic subsides, Alkem Laboratories predicts that inflationary pressures and shifting regulatory standards will be the primary concerns to keep an eye on, and that normal business operations would allow the Indian pharmaceutical industry to resume its 8–11%...
News
Sharp expands its reach to China through partnership with ClinsChain
Sharp, a global leader in contract packaging and clinical supply services, has formed a strategic partnership with China-based ClinsChain to expand its reach and capabilities into the Chinese market.
Sharp will collaborate with ClinsChain - who specialize in providing clinical...
News
Switzerland To Get A $518mn Fill-Finish Plant From Lonza
Lonza, a major CDMO, is to invest $518 million in a new, massive fill-finish manufacturing facility in Stein, Switzerland. According to the firm, the facility will use sustainable construction methods to lower carbon emissions when it is finished in...
News
Pfizer And Touchlight Enter Into A Patent Licence Agreement
Pfizer and another pharmaceutical major, Touchlight, have come to a deal on a significant non-exclusive patent licence. Touchlight is a firm that focuses on enzymatic DNA manufacturing to further enhance genetic therapies.
As a result of the licencing arrangement, Pfizer...
News
AstraZeneca, GSK Overcame Q2 Issues While Roche Stocks Fell
The standard response to any poor performance is to blame the supply chain, which has almost attained the status of a joke. However, it is now one of a serious group of interconnected economic headwinds that also includes the...
News
FDA Allows Licenced Pharmacists To Sell Paxlovid From Pfizer
On July 6, the US Food and Drug Administration modified the COVID-19 antiviral drug Paxlovid's emergency use authorization to permit state-licensed pharmacists to recommend the medication to those who qualify.
Dr. Patrizia Cavazzoni, head of the FDA's Center for Drug Evaluation...
News
Deloitte Latest Survey – Mature R&D Yields Enterprise Value
According to the third Real-World Evidence (RWE) benchmarking survey published in June 2022 by Deloitte, there is a segmentation of outcomes between businesses with more developed organisational and technological RWE capabilities and those with less developed skills.
Since Deloitte's latest...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read